Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Egle

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
International Journal of Molecular Sciences|September 10, 2021
The Role of Neutrophilic Granulocytes in Philadelphia Chromosome Negative Myeloproliferative NeoplasmsDominik Kiem, Sandro Wagner, Teresa Magnes, et al.
Plos One|February 25, 2012
Lysine residue at position 22 of the AID protein regulates its class switch activityRoland Geisberger, Michael Huemer, Franz J Gassner, et al.
Haematologica|September 8, 2006
The effect of IgVH mutational status on the induction of apoptosis by rituximab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: evidence from a clinical phase I/II trialInge Tinhofer, Michael Steurer, Gabriele Leitinger, et al.
Blood|January 27, 2009
PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemiaClaudia Holler, Josefina D Piñón, Ursula Denk, et al.
Plos One|September 12, 2013
Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort levelNinon Taylor, Katharina Grabmeier-Pfistershammer, Alexander Egle, et al.
British Journal of Haematology|July 26, 2014
Kasabach-Merritt phenomenon in hepatic angiosarcomaStefan Habringer, Ann Boekstegers, Lukas Weiss, et al.
Annals of Hematology|January 21, 2014
Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trialGeorg Hopfinger, Thomas Nösslinger, Alois Lang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2011
Complete remission of Waldenström macroglobulinemia with azacitidine and rituximabLukas Weiss, Thomas Melchardt, Daniel Neureiter, et al.
Plos One|November 10, 2018
Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parametersKonstantin Schlick, Teresa Magnes, Lukas Ratzinger, et al.
Blood|July 11, 2006
Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemiaInge Tinhofer, Gabriele Rubenzer, Claudia Holler, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
International Journal of Molecular Sciences|September 10, 2021
The Role of Neutrophilic Granulocytes in Philadelphia Chromosome Negative Myeloproliferative NeoplasmsDominik Kiem, Sandro Wagner, Teresa Magnes, et al.
Plos One|February 25, 2012
Lysine residue at position 22 of the AID protein regulates its class switch activityRoland Geisberger, Michael Huemer, Franz J Gassner, et al.
Haematologica|September 8, 2006
The effect of IgVH mutational status on the induction of apoptosis by rituximab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: evidence from a clinical phase I/II trialInge Tinhofer, Michael Steurer, Gabriele Leitinger, et al.
Blood|January 27, 2009
PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemiaClaudia Holler, Josefina D Piñón, Ursula Denk, et al.
Plos One|September 12, 2013
Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort levelNinon Taylor, Katharina Grabmeier-Pfistershammer, Alexander Egle, et al.
British Journal of Haematology|July 26, 2014
Kasabach-Merritt phenomenon in hepatic angiosarcomaStefan Habringer, Ann Boekstegers, Lukas Weiss, et al.
Annals of Hematology|January 21, 2014
Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trialGeorg Hopfinger, Thomas Nösslinger, Alois Lang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2011
Complete remission of Waldenström macroglobulinemia with azacitidine and rituximabLukas Weiss, Thomas Melchardt, Daniel Neureiter, et al.
Plos One|November 10, 2018
Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parametersKonstantin Schlick, Teresa Magnes, Lukas Ratzinger, et al.
Blood|July 11, 2006
Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemiaInge Tinhofer, Gabriele Rubenzer, Claudia Holler, et al.
Pageof 13